Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Evidence-based treatment of valvular heart disease].

Created on 24 Oct 2026

Authors

Felix S Nettersheim, Stephan Baldus

Published in

Innere Medizin (Heidelberg, Germany). Oct 23, 2026. Epub Oct 23, 2026.

Abstract

Valvular heart disease is a major cause of cardiovascular morbidity and mortality worldwide. As the prevalence of most valvular heart diseases increases with age, population ageing has led to a substantial increase in disease burden. Due to advanced age or significant comorbidities, many patients are considered unsuitable for conventional surgery. Whereas medical therapy was therefore often the only treatment option in the past, the rapid evolution of transcatheter interventions has fundamentally transformed the management of valvular heart disease over the past two decades. Today, effective catheter-based treatment options are available for virtually all valvular pathologies. For patients with severe symptomatic aortic stenosis, the prognostic benefit of transcatheter aortic valve replacement is firmly established. Large randomized trials have demonstrated non-inferiority of transcatheter aortic valve replacement compared with surgical aortic valve replacement across most patient populations, leading to an expanding use of this approach in younger and lower-risk patients. Similarly, transcatheter edge-to-edge repair for mitral and tricuspid regurgitation has been shown to improve symptoms, quality of life, and heart failure-related hospitalizations. In carefully selected patients with secondary mitral regurgitation, this strategy also confers a survival benefit. In addition, dedicated transcatheter devices have recently emerged as promising treatment options for native aortic regurgitation. Given the rapid evolution of transcatheter therapies, current efforts are increasingly focused on selecting the optimal treatment strategy for the individual patient and determining the optimal timing of intervention.

PMID:
42909507
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement